1Kawashima T. The autonomic nervous system of the human heart with special reference to its origin, course, and peripheral distribution. Anat Embryol (Berl), 2005, 209: 425-438.
2Onkka P, Maskoun W, Rhee KS, et al. Sympathetic nerve fibers and ganglia in canine cervical vagus nerves: localization and quantitation. Heart Rhythm, 2013, 10: 585-591.
3Park HW, Shen M J, Han S, et al. Neural control of ventricular rate in ambulatory dogs with pacing-induced sustained atrial fibrillation. Circ Arrhythm Eleetrophysiol, 2012, 5:571-580.
4Seki A, Green HR, Chen PS, et al. Sympathetic nerve fibers in human cervical and thoracic vagus nerves. Heart Rhythm, 2014, 11: 1411- 1417.
5Ogawa M, Zhou S, Tan AY, et al. Left stellate ganglion and vagal ne- rve activity and cardiac arrhythmias in ambulatory dogs with pacing- induced congestive heart failure. J Am Coil Cardiol, 2007, 50: 335- 343.
6Coumel P, Attuel P, Lavallee J, et al. The atrial arrhythmia syndrome of vagal origin. Arch Mal Coeur Vaiss, 1978, 71: 645-656.
7Ogawa M, Zhou S, Tan AY, et al. Left stellate ganglion and vagal ne- rve activity and cardiac arrhythmias in ambulatory dogs with pacing- induced congestive heart failure. J Am Coil Cardiol,2007, 50: 335- 343.
8Andrade J, Khairy P, Dobrev D, et al. The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms. CircRes, 2014, 114: 1453- 1468.
9Patterson E, Lazzara R, Szabo B, et al. Sodium-calcium exchange initi-ated by the 2 Ca transient: an arrhythmla tmgger within pulmonary veins. J Am Coil Cardiol, 2006, 47:1196-1206.
10Voigt N, Heijman J, Wang Q, et al. Cellular and molecular mechanisms of atrial arrhythmogenesis in pati-ents with paroxysmal atrial fibrillation. Circulation, 2014, 129: 145-156.
二级参考文献40
1Ball J, Carrington M J, MeMurray J J, el al. Atrial fibrillation: profile and burden of an ewdving epidemic in the 21st tenths,, lnt J Cardiol, 2013, 167: 1807-1824.
2He XZ, Wang HY. Shen Y. el al. Cardiomyocyte progenitors in a canine pulmonary vein model of persistent atrial fibrillalion. J Cardiol, 2012, 60: 242-247.
3Namekala I, Tsuneoka Y, Tanaka H. Eleclrophysiological and pharmacological properties of the pulmonary vein myocardinm. Biol Pharm Bull, 2013, 36: 2-7.
4Harem S. Biology of the substrata of alrial fibrillation. Biol Aujourdhui, 2012, 206: 5-9.
5Xu Y, Sharma D, Li G, et al, Atrial remodeling: New pathopiaysiological mechanism if atrial fihrillation. Med Hypolheses, 2013, 80: 53-56.
6Sasaki N, Okumura Y. Watanabe I, et al. Pulmonary vein remnant as a trigger site for atrial fibrillalinn. Circ J, 2013, 77: 494-496.
7Medi C, Kalman JM, Ling LH, et al. Atrial electrical and structural remodeling associated with longstanding pulmonary hypertension and right ventricular hypertrophy in humans. J Cardiovasc Electrophysiol, 2012, 23: 614-620.
8Sossalla S. Kallmeyer B. Wagner S, et al. Altered Na+ eurrents in atrial fibrillation effects of ranolazine on arrhythmias and contractility in human atrial myocardium. J Am Coil Cardiol. 2010, 55: 2330-2342.
9Caballero R, de la Fuente MG, G6mez R, at al. In humans, chronic atrial fibrillation decreast, s lhe lransient outward currenI and uhrarapid component of tile delayed rectifier currenl differentially <>n each atria and increases the slow component of the delayed rectifier current in both. J Am Coil Cardiol, 2010, 55: 2346-2354.
10Voigt N, Li N, Wang Q. et al. Enhanced sarcnplasmic reticulum Ca2+ leak and increased Na+-Ca2+ exchanger function underlie delayed afterdepolarizations in patients with chronic atrial fibrillation. Circulation, 2012, 125: 2059-2070.
